Результаты поиска

Nasopharyngeal Carcinoma Presenting with Extensive Osseous Metastases and Intracranial Involvement: A Case Report.

INTRODUCTION: Nasopharyngeal carcinoma (NPC) rarely presents with extensive osseous metastases and intracranial involvement as initial manifestations, posing diagnostic challenges. This report details an unusual case, highlighting its unique clinical course and the importance of considering NPC in atypical metastatic presentations, particularly when an association with Epstein-Barr virus (EBV) is identified. CASE PRESENTATION: An approximately 60-year-old female presented with a progressively enlarging forehead lesion, headaches, and subsequent findings of calvarial lytic lesions with intracr

Network analysis of cross-income-level collaboration on multiple myeloma in sub-Saharan Africa.

Cross-income-level collaboration (CILC) is crucial for developing global health approaches that benefit low- and middle-income countries (LMICs). Multiple myeloma (MM) is a representative example of a complex, understudied disease in sub-Saharan Africa (SSA). Based on publications, we developed a network analysis tool to assess scientific collaborations. Here, we present findings from a systematic analysis of publications retrieved from PubMed between January 2002 and June 2022. We evaluated individual institutional contributions and collaboration patterns using undirected weighted networks. O

Evolution of real-world frontline treatment patterns in multiple myeloma.

AbstractThe number of Food and Drug Administration-approved treatments for multiple myeloma (MM), the second most common hematologic malignant neoplasm, has increased substantially over the past 2 decades. Treatment decisions have become more complex over time, and there is variable adoption of new agents in clinical practice. Survival trends have improved with novel therapies; however, these trends are not equitably distributed across patient populations. Although randomized clinical trials have guide treatment strategies, their exclusion of older, medically complex, and socioeconomically dis

Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability.

BackgroundThe objectives of this study were to quantitatively assess the geographic heterogeneity of cancer prevalence in selected Western Countries and to explore the associations between its determinants.MethodsFor 20 cancer sites, 5-year cancer prevalence, incidence, and survival were observed and age standardised for the mid 2000s in the United States, Nordic European Countries, Italy, Australia, and France.ResultsIn Italy, 5-year crude prevalence for all cancers was 1.9% in men and 1.7% in women, while it was ∼1.5% in all other countries and sexes. After adjustment for the different age d

Changing trends of the diseases burden attributable to high BMI in Asia from 1990 to 2019: results from the global burden of disease study 2019.

ObjectiveTo analyse the trends of diseases burden attributed to high body mass index (BMI), including overweight and obesity, in Asia from 1990 to 2019.DesignObservational study.SettingThe data of 45 countries and regions in Asia were obtained from the Global Burden of Disease Study 2019 database.Main outcome measuresNumbers, age-standardised rate (ASR) of deaths and disability-adjusted life years (DALYs), and the corresponding estimated annual percentage changes (EAPCs), attributable to high BMI in Asia from 1990 to 2019, were analysed by regions, genders and age. We also analysed changes in

Cancer incidence in the vicinity of open landfills in Guadeloupe, French West Indies.

BackgroundPeople living in the vicinity of a landfill may be exposed to a wide range of pollutants, with possible subsequent health effects, including increased risks of cancer. The aim of the present study was to explore associations between cancer incidence and proximity to the main open landfills in Guadeloupe.MethodsWe used data from the Guadeloupe cancer registry over the period from 2008 to 2017. We conducted analyses for the 18 most frequent cancer sites. We used the Besag York and Mollié model to study the association between cancer incidence and distance from a landfill, with adjustme

Совпадение в полном тексте источника
… Spatial analytical methods and geographic information systems: use in health research and epidemiology. Epidemiol Rev. 1999;21:143–61. 14. Bhakkan-Mambir B, Deloumeaux J, Luce D. Geographical variations of cancer incidence in Guadeloupe, French West Indies. BMC Cancer. 2022;22:783. 15. …

Библиометрический анализ исследований в области контроля за конкретными случаями, касающихся связи между аллеями АВП и множественным склерозом у взрослых.

Множественный склероз (MS) представляет собой сложное аутоиммунное заболевание, которое влияет на центральную нервную систему (CNS), при этом генетические и экологические факторы играют важную роль в ее развитии и развитии. Одним из наиболее важных генетических факторов, связанных с MS, является генный комплекс HLA. Взаимосвязь между ВУЗом и МЗ стала предметом многочисленных исследований, однако до настоящего времени не сообщалось о результатах библиометрического анализа этих исследований. Поэтому цель этого исследования состояла в том, чтобы дать всеобъемлющий обзор выпуска публикаций, влияни

Systematic Review of Case Reports and Case Series Published Between 2015 and 2025 on the Use of Biomaterials for Closure of Oroantral Fistula.

Oroantral fistulas (OAFs) challenge the clinical decision-making of oral surgeons, requiring selection of an effective biomaterial for successful closure. This systematic review aims to evaluate recent biomaterials and techniques for closing oroantral fistulas, as reported in case reports and series. The goal of this review was to assess how different biomaterials affect the clinical closure of OAFs and oroantral communication. This systematic review followed PRISMA guidelines. Multiple scientific databases (Scopus, Web of Science, Cochrane Library) were comprehensively searched using relevant

Prevalence and determinants of polypharmacy among cancer patients: a systematic review and meta-analysis.

BACKGROUND: Polypharmacy (PP) is a rising clinical challenge among patients with a cancer diagnosis. Uncertainty remains regarding its exact burden, exact prevalence estimates, and definitional themes in this vulnerable cohort of patients. METHODS: We searched PubMed, EMBASE, Scopus, the Cochrane Database of Systematic Reviews (CDSR), and Google Scholar, for studies published between 2000 and 2025 for eligible studies reporting on polypharmacy in cancer patients. These were critically appraised for eligibility and inclusion by two independent reviewers. Using quality and random effect models,

ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder.

Geographically dispersed patients, inconsistent treatment tracking, and limited infrastructure slow research for many orphan diseases. We assess the feasibility of a patient-powered study design to overcome these challenges for Castleman disease, a rare hematologic disorder. Here, we report initial results from the ACCELERATE natural history registry. ACCELERATE includes a traditional physician-reported arm and a patient-powered arm, which enables patients to directly contribute medical data and biospecimens. This study design enables successful enrollment, with the 5-year minimum enrollment g

Variation in Kidney Transplant Referral, Living Donor Contacts, Waitlisting, and Kidney Transplant Across Regional Renal Programs in Ontario, Canada: A Population-Based Cohort Study.

BackgroundPrevious studies conducted in publicly and privately funded health care systems suggest that access to kidney transplants may vary depending on where a patient receives their kidney care. It is poorly understood whether variability exists across the key steps required to receive a kidney transplant in a publicly funded health care system.ObjectiveTo determine whether there is variation across Ontario's regional renal programs (RRPs) in key steps completed toward receiving a kidney transplant.DesignPopulation-based cohort study from November 1, 2017, to December 31, 2021, using linked

Global cancer statistics for children: Two decades of change and projections to 2050.

Reliable, contemporary estimates of the global childhood cancer burden remain scarce, particularly in the post-coronavirus disease 2019 (COVID-19) era. By using data from the Global Burden of Disease 2021 and Global Cancer Observatory 2022 projects, the authors evaluated the childhood cancer burden at global, regional, and national levels, characterizing temporal and projected trends, and analyzed the data according to disparities by geography and socioeconomic development. From 2000 to 2021, the age-standardized incidence rate (ASIR) and the age-standardized mortality rate (ASMR) of childhood

Всеобъемлющий анализ связанных с этим негативных явлений на основе базы данных Системы отчетности об отрицательных явлениях УЛХ.

ЦЕЛЬ: Этрасимод, избирательный sphingosine-1-phosphate Рецепторный модулятор — это новое лечение язвительного колита. Цель этого исследования заключается в анализе реального распределения неблагоприятных явлений в мире, связанных с " Этрасимод " , с использованием базы данных Системы отчетности о неблагоприятных явлениях УЛХ (FAERS), выявлении ключевых сигналов " AE " и проведении всеобъемлющей оценки безопасности. МАТЕРИАЛЫ И МЕТОДЫ: Данные Э, связанные с этрасимозом, из базы данных FAERS между Q4 2023 и Q1 2025 , анализировался с использованием частотных и байесовских мет

Pathogenesis of Oral Toxicities Associated with Targeted Therapy and Immunotherapy.

Targeted therapy and immunotherapy have redefined cancer treatment. While they have enhanced tumor response and improved survival rates in many cancer types, toxicities continue to occur, and these often involve the oral cavity. Broadly reported as "mucositis" or "stomatitis," oral toxicities induced by targeted therapies differ clinically and mechanistically from those associated with conventional chemotherapy. Manifesting primarily as mucosal lesions, salivary gland hypofunction, or orofacial neuropathies, these oral toxicities may nonetheless lead to significant morbidity and impact patient

Trends and Disparities in Cancer-Related Mortality Among Adults With Diabetes in the United States: 1999-2019.

AimCancer and diabetes are major public health concerns, with diabetes linked to increased cancer-related mortality. However, national trends and disparities remain underexplored.MethodsUsing CDC WONDER data, we analysed deaths where both diabetes and cancer were listed as causes. Age-adjusted mortality rates (AAMRs) were calculated for diabetic cancer patients aged ≥ 25 years and stratified by demographics and geography. Joinpoint regression estimated annual percent changes (APCs) and average annual percent changes (AAPCs).ResultsFrom 1999 to 2019, 699,007 cancer-related deaths occurred among

Risk of cancer in patients with thalassemia and sickle cell disease: a systematic review.

BACKGROUND: Individuals with thalassemia or sickle cell disease (SCD) are at an elevated risk of developing cancer, yet the full extent of this risk remains inadequately characterised. METHODS: We conducted a systematic review using three databases (MEDLINE, EMBASE and Scopus) to compare the cancer risk in patients with thalassemia and SCD with that of the general population. Secondly, we assessed the impact of other putative risk factors in patients with thalassemia and SCD on cancer risk. RESULTS: Five studies from four countries were included, encompassing a total of 24,439 individuals ov

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).

This randomized, phase III, open-label, multicenter study compared carfilzomib monotherapy against low-dose corticosteroids and optional cyclophosphamide in relapsed and refractory multiple myeloma (RRMM). Relapsed and refractory multiple myeloma patients were randomized (1:1) to receive carfilzomib (10-min intravenous infusion; 20 mg/m2 on days 1 and 2 of cycle 1; 27 mg/m2 thereafter) or a control regimen of low-dose corticosteroids (84 mg of dexamethasone or equivalent corticosteroid) with optional cyclophosphamide (1400 mg) for 28-day cycles. The primary endpoint was overall survival (OS).

An Appraisal of the Oleocanthal-Rich Extra Virgin Olive Oil (EVOO) and Its Potential Anticancer and Neuroprotective Properties.

Dietary consumption of olive oil represents a key pillar of the Mediterranean diet, which has been shown to exert beneficial effects on human health, such as the prevention of chronic non-communicable diseases like cancers and neurodegenerative diseases, among others. These health benefits are partly mediated by the high-quality extra virgin olive oil (EVOO), which is produced mostly in Mediterranean countries and is directly made from olives, the fruit of the olive tree (Olea europaea L.). Preclinical evidence supports the existence of antioxidant and anti-inflammatory properties exerted by t

Доступ к терапии перенаправления T-Cell в Мультимиломе: пациент, сторож и физиологическая точка зрения на осведомленность и барьеры.

Справочная информация: Лечение перенаправления Т-клеток (TCRTs), включая терапию CAR-T-клеток и биконкретные антитела, изменило методы лечения повторной/охлажденной множественной миеломы (MM), однако реальное усыновление по-прежнему ограничено из-за ограничений в плане осведомленности и доступа пациентов, лиц, обеспечивающих уход, и врачей. Методы: Мы провели перекрестное исследование (июнь-сентябрь) 2025) с использованием одобренных IRB обследований СВОД, распространяемых среди пациентов, имеющих MM (через MyChart), лиц, обеспечивающих уход за получателями ТСПР (по электронной почте) и общинн

A Rapid Systematic Review on the Experiences of Cancer Survivors Residing in Rural Areas during the COVID-19 Pandemic.

The COVID-19 pandemic has caused considerable disruption to cancer care and may have exacerbated existing challenges already faced by cancer survivors from rural areas. This has created a need for a rapid evidence synthesis to inform the development of tailored interventions that address the specific needs of rural cancer survivors who continue to be affected by the pandemic. The review was conducted following guidance from the Cochrane Rapid Review Methods Group. Database searches were performed via the EBSCOHost interface (includes MEDLINE, CINAHL, PsycINFO) on 25 May 2022 and supplemented w